Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
39 /100
MEDIUM RISK
Score updated Oct 13, 2026

LAB — Standard BioTools Inc. Dilution Risk Tracker

Track LAB dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track LAB — Get alerts when the score changes →

As of October 13, 2026, Standard BioTools Inc. (LAB) has a DilutionWatch DilutionScore of 39/100, rated MEDIUM dilution risk. Standard BioTools Inc. has a market capitalization of $258.24M, 392.58M shares outstanding, 155 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
10
📊 Float Risk
39
⚠️ Warrant Exposure
40
🔄 Convertible Debt
60

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 39%
🔄 Reverse Split model est. 55%
• 50-day avg $0.96 below $1 exchange minimum
🔁 Convertible Conversion model 40%
• Significant convertible debt: 21% potential dilution
• Elevated convertible risk (60/100)
🔔 Track LAB — Get forecast alerts →

Market Data

Market Cap$258.24M
Shares Outstanding392.58M
Float210.62M
Cash$310.90M
Debt$29.49M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore39/100DilutionWatch score record
Shares Outstanding392.58MVerified float table or market cache
Public Float210.62MVerified float table or market cache
Market Cap$258.24MMarket data cache
Cash Runway25.2 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 14.0% shares (2026Q1 vs prior)
155 institutional holders · 348.90M shares
#1 Casdin Capital, LLC 88.78M shares
#2 VIKING GLOBAL INVESTORS LP 58.65M shares
#3 MAK CAPITAL ONE LLC 26.17M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest2.52M
Days to Cover2.7
% of Float1.2%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-16
xbrl XBRL CONVERTIBLE 2025-03-11
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual LAB Dilution Snapshot

Standard BioTools Inc. (LAB) has a DilutionScore of 39/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

LAB's DilutionScore is currently 39/100 (Medium risk), with 2 score changes tracked over 89 days. The score improved from 34/100 (Medium risk).

Period Score Risk Level Duration
Oct 10 – Oct 13, 202639/100MEDIUM4 days
Jul 17 – Oct 09, 202634/100MEDIUM84 days
Jul 16, 202635/100MEDIUM1 day

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

LAB shares outstanding have increased 1.5% from 384.57M (Mar 2026) to 390.37M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 27, 2026390.37M210.62M▲ 0.06%
May 25, 2026390.37M210.48M▼ 0.05%
May 24, 2026390.37M210.59M▲ 0.01%
May 18, 2026390.37M210.57M▼ 2.86%
May 10, 2026390.37M216.77M▲ 0.56%
May 08, 2026390.37M215.57M▼ 0.42%
Apr 18, 2026390.07M216.47M▼ 0.20%
Apr 03, 2026390.07M216.90M▲ 408.89%
Mar 22, 2026390.07M42.62M▲ 1.16%
Mar 12, 2026384.57M42.13M▼ 0.04%
Mar 05, 2026384.57M42.15M▼ 0.05%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track LAB Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment LAB files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking LAB — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for LAB
LAB FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.